PDCD1 and melanoma: It would also be critical to determine whether the elevated cytokine production we have observed positively correlates with cancer types that respond well to anti-PD-1 therapy, such as lung cancer and melanoma, but does not correlate with cancer types that do not respond to anti-PD-1 therapy, such as prostate and pancreatic cancers.